NeuroSense trades close to 90 cents as next $1 Nasdaq threshold comes into view
NeuroSense Therapeutics Ltd. added 5 cents to 87 cents during Tuesday’s session as shares edged higher. That kept the ALS biotech under a key Nasdaq price threshold, but closer. Volume was about 78,500 shares. NeuroSense’s market cap was around $15.7 million, as the stock moved between 84 and 87 cents. NeuroSense is under pressure after warnings from Nasdaq about two key listing standards — the $1 minimum bid price and a $35 million market value of listed securities, or MVLS. Nasdaq uses MVLS to track the value of securities on its exchange. NeuroSense has until Sept. 29, 2026, to fix both issues. The company needs its shares to close at or above $1 for at least 10 days in a